Banner
HomeBest Practices → 'Living Drug' That Fights Cancer By Harnessing Immune System Clears Key Hurdle

'Living Drug' That Fights Cancer By Harnessing Immune System Clears Key Hurdle Print E-mail
Written by FHI's Week in Review   
Monday, 17 July 2017 00:00

Rob Stein reports for Health News Florida on 7/12/17:
 
A new kind of cancer treatment that uses genetically engineered cells from a patient's immune system to attack their cancer easily cleared a crucial hurdle Wednesday...The treatment takes cells from a patient's body, modifies the genes, and then re-infuses those modified cells back into the person who has cancer. If the agency approves, it would mark the first time the FDA has approved anything considered to be a gene therapy product...The treatment is part of one of the most important developments in cancer research in decades - finding ways to harness the body's own immune system to fight cancer.

Last Updated on Wednesday, 19 July 2017 11:58
 


Banner
Website design, development, and hosting provided by
Netphiles